Tue, April 9, 2013
Mon, April 8, 2013

Biocurex Inc (OTC:BOCX), Down By 33.33% ($0.01) From $0.015 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearis

April 8, 2013 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Wednesday, March 27th 2013 stating that Biocurex Inc (OTC:BOCX) was expected to go Down due to the Bearish conditions presented in the following report. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=bocx&id=357092

At the time this story was written, Biocurex Inc (OTC:BOCX) is Down By $0.01 (33.33%) since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.

The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

Biocurex Inc (OTC:BOCX) - BioCurex, Inc., a development stage company, engages in developing, producing, marketing, and licensing products based on patented and proprietary technology in the area of cancer diagnostics. It develops various product candidates based on RECAF technology. The company offers its RECAF technology in three basic formats, including automated testing in large clinical and hospital laboratories; non-automated or manual testing by clinicians in smaller laboratory settings; and point-of-care rapid test formats for physicians offices, and urgent care facilities. It also develops RECAF marker, a cancer marker, which is used in blood tests to detect the presence of cancer in humans and animals. The company was formerly known as Whispering Oaks International, Inc. and changed its name to Biocurex, Inc. in October 2009. Biocurex, Inc. was incorporated in 1997 and is based in Richmond, Canada.. There is a failure to deliver in shares of BOCX

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net